Back

Global prevalence of early menopause and its association with cardiovascular outcomes: the PURE study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Specific intervention for cardiovascular disease in women Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Simone Marschner

University of Sydney, Sydney (Australia)

5 More presentations in this session

Presentation thumbnail
Clinical aspects of female patients with Brugada syndrome: results from a nationwide multicenter study in Japan
Doctor S. Chishaki (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Sudden death in pregnancy: incidence, characteristics, and management
Doctor O. Weizman (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Sex differences in effects of pharmacological treatment of heart failure: a meta-analysis and meta-regression of randomized controlled trials
Ms M. Van Der Bijl (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Pathophysiologic basis of angina symptoms in women with nonobstructive atherosclerosis using artificial intelligence-enabled plaque characterization from coronary computed tomography angiography
Mr R. Wolny (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Women with polycystic ovarian syndrome are at increased associated risk of acute myocardial infarction and ischemic stroke
Doctor E. Havers-Borgersen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Specific intervention for cardiovascular disease in women
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Earlier menopause is related to adverse left ventricular morphology and function in the UK Biobank
thumbnail
Congress Presentation
Beyond the change: exploring age of menopause, lifestyle, and cardiovascular risk in women
thumbnail
Congress Presentation
Heart failure in women: special considerations - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources